EX-12 8 c92539exv12.htm STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS exv12
 

     EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS FROM CONTINUING

OPERATIONS TO FIXED CHARGES

Eli Lilly and Company and Subsidiaries
(Dollars in millions)

                                         
    Years Ended December 31,  
    2004     2003     2002     2001     2000  
 
                                        
Consolidated pretax
income from continuing
operations
   $ 2,941.9     $ 3,261.7     $ 3,457.7     $ 3,506.9     $ 3,858.7  
 
                                        
Interest from continuing
operations and other
fixed charges
     162.9       121.9       140.0       253.3       225.4  
 
                                        
Less interest capitalized
during the period from
continuing operations
     (111.3 )     (60.9 )     (60.3 )     (61.5 )     (43.1 )
 
    
 
                                        
Earnings
   $ 2,993.5     $ 3,322.7     $ 3,537.4     $ 3,698.7     $ 4,041.0  
 
    
 
                                        
Fixed charges
   $ 162.9     $ 121.9     $ 140.0     $ 253.3     $ 225.4  
 
    
 
                                        
Ratio of earnings to
fixed charges
     18.4       27.3       25.3       14.6       17.9